The management of chronic skin conditions like atopic eczema and psoriasis is rarely a one size fits all process. Because the human body undergoes significant physiological shifts at different life stages, medical treatments must be carefully tailored to ensure both safety and effectiveness. In the UK, healthcare providers follow specific clinical pathways for children, pregnant women, and the elderly to account for differences in skin thickness, immune response, and the way medications are processed by the liver and kidneys. These adjustments are vital for preventing side effects while maintaining control over the skin condition.
What We’ll Discuss in This Article
- Adjusting the potency of topical treatments for children.
- The safety of steroid and non-steroid creams during pregnancy.
- Managing chronic skin disease in the elderly with multiple medications.
- The importance of monitoring growth in paediatric eczema patients.
- Treatment options for breastfeeding mothers.
- Avoiding drug interactions and skin fragility in older patients.
1. Managing skin conditions in children
Children, especially infants and toddlers, have much thinner skin than adults. This means they absorb topical medications far more readily, which increases the risk of systemic side effects from strong creams.
Stepwise topical care
GPs and paediatric dermatologists use a cautious stepwise approach. This involves using the lowest potency steroid possible to control the flare. For example, while an adult might use a potent steroid on their arm, a child may be prescribed a moderate or mild version for the same area.
Monitoring growth and development
In cases of severe childhood eczema where large amounts of topical steroids are used, or when oral treatments are required, doctors must monitor the child’s height and weight. NICE standards emphasise that significant skin disease can impact sleep and growth, so regular reviews are essential to ensure the child is meeting their developmental milestones.
2. Treatment during pregnancy and breastfeeding
The primary concern during pregnancy is the safety of the developing baby. Many standard skin treatments are safe, but others must be avoided entirely.
Safe topical options
Most emollients and mild to moderate topical steroids are considered safe for use during pregnancy. However, they should be applied only to the affected areas to minimise any potential absorption into the bloodstream. Calcineurin inhibitors like tacrolimus are generally used with more caution and only when necessary.
Systemic medications to avoid
Certain oral treatments for psoriasis, such as methotrexate and acitretin, are strictly avoided because they can cause serious birth defects. Women of childbearing age who are taking these medications in the UK must use effective contraception. If a pregnant woman requires systemic treatment, doctors may switch her to ciclosporin or specific biological therapies that have a proven safety record in pregnancy.
Note: Always inform your GP or midwife if you are using medicated skin creams, as some ingredients can be absorbed and may need to be reviewed during your pregnancy.
3. Considerations for elderly patients
As we age, the skin naturally becomes thinner, drier, and more fragile. This change in skin structure, combined with other health conditions, alters how eczema and psoriasis are managed.
Fragile skin and steroids
Elderly patients are at a higher risk of skin atrophy (thinning) and easy bruising from topical steroids. Clinicians often prescribe weaker steroids or suggest more frequent use of heavy, greasy emollients to bolster the skin barrier.
Managing Polypharmacy
Many older adults take multiple medications for conditions like heart disease or diabetes. Some of these drugs, such as beta-blockers or lithium, can actually trigger or worsen psoriasis. Additionally, systemic skin medications must be used at lower doses if the patient has reduced kidney or liver function, which is common in older age. This start low and go slow approach helps prevent the buildup of medication in the body.
Conclusion
Treatment for eczema and psoriasis must be adapted to the specific needs of the patient’s life stage. For children, the focus is on safety and growth; for pregnant women, it is the protection of the fetus; and for the elderly, it is the management of skin fragility and complex medication schedules. By following these tailored clinical guidelines, UK healthcare providers ensure that every patient receives the most appropriate and safe care for their unique circumstances.
How does treatment differ for children?
Children have thinner skin that absorbs medication more easily, so doctors use the mildest effective topical steroids and monitor growth and development to ensure their condition is not impacting their wellbeing.
Is it safe to use medicated creams during pregnancy?
Many emollients and mild steroids are considered safe, but always check with your GP. Some systemic treatments for psoriasis can cause birth defects and must be strictly avoided or replaced with safer alternatives.
Why does skin management change as we age?
Elderly skin is thinner and more fragile, increasing the risk of thinning or bruising from steroids. Doctors often prescribe milder treatments and adjust doses to account for potential interactions with other medications.
Can some regular medications worsen skin conditions?
Yes. Drugs like beta-blockers or lithium, commonly taken for other health issues, can trigger or exacerbate psoriasis. Always inform your GP about all medications you are taking.
Are there special precautions for breastfeeding?
Yes. Always inform your doctor if you are breastfeeding, as some ingredients in skin treatments can pass into your milk. Your GP will review your regimen to ensure it remains safe for your baby.
What is the “start low and go slow” approach?
This is a clinical strategy used for elderly patients to prevent medication buildup. It involves using the lowest effective doses to manage the skin while protecting kidney and liver health.
Authority Snapshot (E-E-A-T Block)
This article examines how skin condition management is adapted for special patient populations to ensure clinical safety. It is written by the MyPatientAdvice Medical Writing/Research Team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in primary care and maternal health. All information follows the safety protocols and prescribing standards provided by the NHS and NICE for 2026.
